Suppr超能文献

CI-867,一种新型半合成青霉素:体外研究

CI-867, a new semisynthetic penicillin: in vitro studies.

作者信息

Weaver S S, Bodey G P

出版信息

Antimicrob Agents Chemother. 1980 Dec;18(6):939-43. doi: 10.1128/AAC.18.6.939.

Abstract

CI-867, a new semisynthetic penicillin, has exhibited broad-spectrum activity in vitro against gram-positive cocci, except penicillin G-resistant Staphylococcus aureus, and against gram-negative bacilli. It was especially active against Pseudomonas aeruginosa and as active as mezlocillin and piperacillin against Klebsiella pneumoniae. CI-867 was bactericidal against most organisms. Its activity was greatly reduced when the inoculum was increased from 10(5) to 10(7) organisms per ml.

摘要

CI - 867是一种新型半合成青霉素,在体外对革兰氏阳性球菌(除耐青霉素G的金黄色葡萄球菌外)和革兰氏阴性杆菌具有广谱活性。它对铜绿假单胞菌特别有效,对肺炎克雷伯菌的活性与美洛西林和哌拉西林相当。CI - 867对大多数微生物具有杀菌作用。当接种量从每毫升10⁵个菌增加到10⁷个菌时,其活性大大降低。

相似文献

1
CI-867, a new semisynthetic penicillin: in vitro studies.CI-867,一种新型半合成青霉素:体外研究
Antimicrob Agents Chemother. 1980 Dec;18(6):939-43. doi: 10.1128/AAC.18.6.939.
4
7
Piperacillin: in vitro evaluation.哌拉西林:体外评估。
Antimicrob Agents Chemother. 1978 Jul;14(1):78-87. doi: 10.1128/AAC.14.1.78.
10
Azlocillin: a new broad spectrum penicillin.
J Antimicrob Chemother. 1983 May;11 Suppl B:21-31. doi: 10.1093/jac/11.suppl_b.21.

引用本文的文献

本文引用的文献

1
In vitro evaluation of cefoperazone.头孢哌酮的体外评价。
Antimicrob Agents Chemother. 1980 Mar;17(3):423-7. doi: 10.1128/AAC.17.3.423.
4
Causes of death in patients with malignant lymphoma.恶性淋巴瘤患者的死亡原因。
Am J Med Sci. 1974 Aug;268(2):97-106. doi: 10.1097/00000441-197408000-00003.
5
Proceedings: Causes of death in cancer patients.会议记录:癌症患者的死因
Cancer. 1974 Feb;33(2):568-73. doi: 10.1002/1097-0142(197402)33:2<568::aid-cncr2820330236>3.0.co;2-2.
10
Piperacillin: in vitro evaluation.哌拉西林:体外评估。
Antimicrob Agents Chemother. 1978 Jul;14(1):78-87. doi: 10.1128/AAC.14.1.78.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验